"Das Helios Amper-Klinikum Dachau, ein Krankenhaus der Schwerpunktversorgung (Stufe II) mit 435 Betten, bietet neben moderner Notfallversorgung und einem breiten Behandlungsspektrum spezialisierte Angebote, die zu einer überregionalen Bedeutung beitragen. Das Dachauer Klinikum versorgt jährlich rund 22.000 stationäre Patienten. Weitere 30.000 Patienten werden ambulant von den über 1.000 Mitarbeitern medizinisch versorgt. Mit einer zentralen Notaufnahme sowie 17 weiteren Fachabteilungen und 18 Kompetenzzentren bieten wir eine umfassende Versorgung auf Universitätsniveau – unter anderem in den Bereichen Innere Medizin, Chirurgie, HNO, Orthopädie, Gynäkologie und Geriatrie."

During the past decade, Helios Amper-Klinikum Dachau conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helios Amper-Klinikum Dachau" #1 sponsor was "Celgene" with 4 trials, followed by "Biotronik AG" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Leipzig Heart Institute GmbH" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helios Amper-Klinikum Dachau" #1 collaborator was "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Helios Amper-Klinikum Dachau" are "Crohn Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Coronary Artery Disease" (2 trials), "Atherosclerosis" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Helios Amper-Klinikum Dachau" in a lesser frequency.

Most popular intervention types in "Helios Amper-Klinikum Dachau" are "Drug" (7 trials), "Device" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "Abbott Laboratories Xience" (1 trials), "Aspirin" (1 trials) and "Biotronik Orsiro" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helios Amper-Klinikum Dachau" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Helios Amper-Klinikum Dachau". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Helios Amper-Klinikum Dachau, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Helios Amper-Klinikum Dachau, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".